Peptide | Asymptomatic | All subjects (n = 14) | All MCADD (n = 10) |
---|---|---|---|
Mean (95% confidence intervals, based on t distribution) | |||
CPT2 | 0.21 | 0.19 (0.09–0.29) | 0.19 (0.10–0.28) |
VLCAD | 1.60 | 1.33 (0.30–2.36) | 1.41 (0.44–2.38) |
MCAD | 0.23 | 0.52 (-0.65–1.68) | 0.18 (0.06–0.29) |
SCAD | 0.38 | 0.21 (0.06–0.37) | 0.21 (0.04–0.38) |
ETFa | 0.36 | 0.32 (0.14–0.50) | 0.34 (0.13–0.54) |
ETFb | 1.03 | 1.09 (0.37–1.81) | 1.12 (0.37–1.81) |
MCKAT | 2.84 | 2.68 (0.53–4.83) | 2.71 (0.58–4.83) |
HADHa | 1.80 | 1.34 (0.57–2.10) | 1.41 (0.64–2.17) |
HADHb | 1.80 | 1.26 (0.35–2.18) | 1.29 (0.39–2.20) |